Product NDC: | 63323-130 |
Proprietary Name: | Doxy 100 |
Non Proprietary Name: | DOXYCYCLINE |
Active Ingredient(s): | 100 mg/10mL & nbsp; DOXYCYCLINE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-130 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062475 |
Marketing Category: | ANDA |
Start Marketing Date: | 20001017 |
Package NDC: | 63323-130-11 |
Package Description: | 10 VIAL in 1 TRAY (63323-130-11) > 10 mL in 1 VIAL |
NDC Code | 63323-130-11 |
Proprietary Name | Doxy 100 |
Package Description | 10 VIAL in 1 TRAY (63323-130-11) > 10 mL in 1 VIAL |
Product NDC | 63323-130 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOXYCYCLINE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20001017 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | DOXYCYCLINE HYCLATE |
Strength Number | 100 |
Strength Unit | mg/10mL |
Pharmaceutical Classes |